首页> 外国专利> METHOD OF TREATING INFECTIONS INDUCED BY HERPES SIMPLEX VIRUSES TYPE I AND II, CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS

METHOD OF TREATING INFECTIONS INDUCED BY HERPES SIMPLEX VIRUSES TYPE I AND II, CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS

机译:治疗I型和II型单纯疱疹病毒,细胞巨细胞病毒和Epstein-BARR病毒引起的感染的方法

摘要

FIELD: medicine.;SUBSTANCE: invention belongs to medicine, notably to infectious diseases and can be used for treatment of infections, induced by herpes simplex viruses type I and II, cytomegalovirus and Epstein-Barr virus. For treatment are used valacyclovir and human recombinant interferon alpha 2. Valacyclovir via ingestion dose is 500 mg twice a day during 5 -10 days. Three million IU of human recombinant interferon alpha 2, diluted in 5 or 10 ml of 0.9% sodium chloride solution is administered twice a day 3 drops into each nostril during 10 days, then 2 drops during 10 days and 1 drop during 10 days.;EFFECT: regimen of human recombinant interferon alpha 2 and valacyclovir administration and dosing aids in increasing of endogenous interferon production resulting in shorter period of infection active phase and longer remission.;1 ex
机译:技术领域本发明属于医学,特别是属于传染性疾病,可用于治疗由I型和II型单纯疱疹病毒,巨细胞病毒和爱泼斯坦-巴尔病毒引起的感染。为了治疗,使用了伐昔洛韦和人重组干扰素α2。伐昔洛韦通过摄入剂量为500 mg,每天两次,持续5 -10天。每天两次在5或10 ml的0.9%氯化钠溶液中稀释的三百万IU人重组干扰素α2,在10天内于每个鼻孔中滴3滴,然后在10天内2滴,在10天1滴。效果:人重组干扰素α2方案和伐昔洛韦的给药及给药剂量有助于增加内源性干扰素的产生,从而缩短了感染活跃期并延长了缓解期。1ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号